Cytopoint

General Drug Information and Indications

Caninized monoclonal antibody (lokivetmab) targeting IL-31 for atopic dermatitis and pruritus in dogs; monthly injection. Monoclonal antibody anti-cytokine therapy (lokivetmab). Mechanism: canine-derived monoclonal antibody that specifically binds and neutralizes interleukin-31 (IL-31) — a key pruritogenic cytokine signaling through JAK1/JAK3 pathway. By blocking IL-31, interrupts itch signal transmission. Monthly subcutaneous injection; sustained-release pharmacokinetics. Key information Monoclonal antibody (lokivetmab). Subcutaneous injection only. Refrigerate; do not freeze. Single-use vial. Allow to warm to room temperature before administration. Dogs only. Once monthly dosing.

How to Give this Medication

SQ injection: administer SQ, typically in the dorsal neck or scruff region. Administer once monthly. Ensure correct dose is drawn based on body weight. Store refrigerated (2–8°C); do not freeze. Bring to room temperature before injection (15–20 min). Single-use vial. If a dose is missed This product is given as a single dose or as part of a defined protocol. Contact your veterinarian if a scheduled administration was missed. Cytopoint is a monthly injection — contact your veterinarian to reschedule.

Side Effects

Injection site reactions (mild, transient — most common adverse effect). GI: vomiting, diarrhea (uncommon). Upper respiratory signs (uncommon). Lethargy (rare). Generally very well tolerated as a biologic therapy. Anaphylaxis (very rare).

Precautions

For animals Dogs only — not for use in cats (feline formulation is Solensia/frunevetmab). Do not administer concurrently with other monoclonal antibody therapies without veterinary supervision. Post-marketing reports of neurological signs (ataxia, paresis) — monitor closely, especially in neurologically predisposed patients. Not approved for use in food-producing animals. For people handling this medication Wash hands thoroughly with soap and water after handling. Monoclonal antibody — Injectable — administered by veterinary staff only. Wash hands thoroughly with soap and water after handling. If accidentally self-injected, seek emergency medical attention immediately. Standard injection safety. Keep out of reach of children.

Overdose

Contact your veterinarian. Monoclonal antibody — overdose with a single extra dose is unlikely to cause serious harm, but contact your vet for guidance.

Cytopoint dosage forms

ProductStrengthFormSizeType
CYTOPOINT 10MG INJECTABLE10 MGInjectable1Commercial
CYTOPOINT 30 MG INJECTABLE30 MGInjectable1Commercial
CYTOPOINT 40MG INJECTABLE: CYTOPOINT40 MGInjectable1Commercial

Sources

This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com); FDA-approved label (Cytopoint, Zoetis)